Infective Endocarditis Diagnosis and Management
Infective Endocarditis Diagnosis and Management is a research topic within Epidemiology. Science Explorer counts 42k research works in it since 1950. 12.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers covers the management, diagnosis, treatment, epidemiology, and prophylaxis of infective endocarditis. It includes discussions on surgical approaches, complications, bacteremia, and guidelines for the diagnosis and antibiotic treatment. The cluster also explores the association between Streptococcus gallolyticus infection and colorectal cancer.
- Infective Endocarditis
- Diagnosis
- Treatment
- Epidemiology
- Prophylaxis
- Surgery
- Complications
- Bacteremia
- Endocarditis Guidelines
- Streptococcus gallolyticus
- Research works
- 42k fractional, since 1950
- In the world top 10%
- 5.1k per year above
- Top-10% rate
- 12.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +31% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Infective Endocarditis Diagnosis and Management research?
By volume, the United States and China publish the most (2.2k and 534 works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 China 534 works
- 3 Japan 475 works
- 4 Italy 410 works
- 5 India 353 works
- 6 Germany 344 works
- 7 Spain 326 works
- 8 United Kingdom 285 works
- 9 France 251 works
- 10 Australia 211 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Infective Endocarditis Diagnosis and Management research?
By volume in 2022–2025, Cleveland Clinic publishes the most Infective Endocarditis Diagnosis and Management research, followed by Mayo Clinic in Arizona and Mayo Clinic.
By volume, 2022–2025
- 1 Cleveland ClinicUnited States 70 works
- 2 Mayo Clinic in ArizonaUnited States 31 works
- 3 Mayo ClinicUnited States 30 works
- 4 All India Institute of Medical SciencesIndia 24 works
- 5 Sichuan UniversityChina 22 works
- 6 Massachusetts General HospitalUnited States 21 works
- 7 Mayo Clinic in FloridaUnited States 20 works
- 8 Emory UniversityUnited States 20 works
- 9 University of PaduaItaly 19 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 19 works
Who are the leading researchers in Infective Endocarditis Diagnosis and Management?
The most-cited researchers publishing on Infective Endocarditis Diagnosis and Management include François Alla, E. Murat Tuzcu and Robert O. Bonow.
- 1 François Alla France 5.1k citations
- 2 E. Murat Tuzcu United States 4.7k citations
- 3 Robert O. Bonow United States 4.5k citations
- 4 Deepak L. Bhatt United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Infective Endocarditis Diagnosis and Management research done?
The largest centres of Infective Endocarditis Diagnosis and Management research in 2022–2025 are Madrid (Spain), New York (United States), Tokyo (Japan) and London (United Kingdom).
Largest cities, 2022–2025
Where is the best place to study Infective Endocarditis Diagnosis and Management?
Among universities, judged by research, University of Lausanne, Sichuan University and Medical University of Silesia score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of LausanneSwitzerland | 54.1 | 27.6% | 4.4× | 11 | +26.6% |
| 2 | Sichuan UniversityChina | 49.4 | 22.9% | 1.8× | 22 | +139.2% |
| 3 | Medical University of SilesiaPoland | 46.5 | 9.8% | 7.2× | 10 | +295.7% |
| 4 | Oregon Health & Science UniversityUnited States | 45.0 | 14.2% | 4.4× | 10 | +261.0% |
| 5 | West Virginia UniversityUnited States | 44.3 | 6.0% | 6.5× | 14 | +579.0% |
| 6 | Harvard UniversityUnited States | 44.0 | 21.6% | 1.8× | 16 | +32.3% |
| 7 | Icahn School of Medicine at Mount SinaiUnited States | 40.7 | 9.8% | 4.8× | 17 | +93.7% |
| 8 | University of PittsburghUnited States | 40.2 | 28.7% | 1.6× | 9 | +17.1% |
| 9 | University of MilanItaly | 39.8 | 20.4% | 2.2× | 11 | +59.7% |
| 10 | The University of Texas Health Science Center at HoustonUnited States | 39.2 | 15.4% | 3.8× | 8 | +139.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Infective Endocarditis Diagnosis and Management research growing?
Output in 2018–2022 was 31% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Infective Endocarditis Diagnosis and Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.